These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35096933)

  • 1. Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation.
    Iacob S; Beckebaum S; Iacob R; Gheorghe C; Cicinnati V; Popescu I; Gheorghe L
    Front Nutr; 2021; 8():787430. PubMed ID: 35096933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.
    Burke A; Lucey MR
    Am J Transplant; 2004 May; 4(5):686-93. PubMed ID: 15084161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
    Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis.
    Carlsson B; Lindén D; Brolén G; Liljeblad M; Bjursell M; Romeo S; Loomba R
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1305-1320. PubMed ID: 32383295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
    Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
    Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians.
    Choudhary NS; Dhampalwar S; Saraf N; Rastogi A; Bhangui P; Soin AS
    J Clin Exp Hepatol; 2024; 14(2):101281. PubMed ID: 38076440
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease.
    Chavan SU; Rathi P; Mandot A
    Clin Exp Hepatol; 2024 Mar; 10(1):39-46. PubMed ID: 38765903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
    Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to prevention of non-alcoholic fatty liver disease after liver transplantation.
    Sharma P; Arora A
    Transl Gastroenterol Hepatol; 2020; 5():51. PubMed ID: 33073046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation for non-alcoholic steatohepatitis: A single center experience.
    Tanaka T; Sugawara Y; Tamura S; Kaneko J; Takazawa Y; Aoki T; Hasegawa K; Sakamoto Y; Yamashiki N; Kokudo N
    Hepatol Res; 2014 Oct; 44(10):E3-E10. PubMed ID: 23834427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
    Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
    Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease.
    Koo BK; Joo SK; Kim D; Lee S; Bae JM; Park JH; Kim JH; Chang MS; Kim W
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2592-2599.e10. PubMed ID: 32062042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.